decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 10 (October)
Correctly code cancer follow-up visits with these tips
Subscribe or sign in to view the full article.
Article Overview
This article explains how cancer surveillance and follow-up visits are commonly handled in medical coding, with attention to evaluation and management coding, ICD-9 diagnosis selection, and the role of payer-specific policy. It is aimed at coders, billers, physicians, and practice staff who need to understand how general coding guidance may differ from local or carrier requirements for post-treatment visits.
Why This Topic Matters
Correctly identifying follow-up cancer visits affects claim validity, diagnosis sequencing, and whether a visit is treated as preventive, problem-oriented, or aftercare-related. The topic is important because payer policies may not align perfectly with general coding guidance, creating a risk of denials or inconsistent billing.
What You Will Learn
- How post-cancer surveillance visits are generally viewed for coding purposes
- How diagnosis coding differs between active treatment and follow-up care
- Why payer policies and local carrier rules may affect claim submission
- What documentation issues can influence the code selected for a follow-up visit
Who Should Read This
- Medical coders
- Billing staff
- Physicians
- Oncology practices
- Primary care practices
- Practice managers
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com